Theodore Scott Nowicki (Theodore Nowicki, Theodore S Nowicki)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Regulatory T Cells

Top Venues

Journal for immunotherapy of cancer

Cancer research communications

Cancer immunology research

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Jack Pengfei Tang, Penelope Lafeuille, Alexandru Socolov, Sheila S Diamond, Jacob Aptekar, Theodore Bruce Moore, Esther H Nie, Mark R Hanudel, Theodore Scott Nowicki
Hypophosphatemia correction reduces ICANS incidence and duration in CAR T-cell therapy: a pooled clinical trial analysis. Cancer research communications (2024)
Vina P Nguyen, Katie M Campbell, Theodore Scott Nowicki, Nila Elumalai, Egmidio Medina, Ignacio Baselga Carretero, Maggie L DiNome, Helena R Chang, Denise K Oseguera, Antoni Ribas, John A Glaspy
A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer. Cancer research communications 3 (8) (2023)
Luke Frankiw, Arun Singh, Cole Peters, Begoña Comin-Anduix, Beata Berent-Maoz, Mignonette Macabali, Kiana Shammaie, Crystal Quiros, Paula Kaplan-Lefko, Ignacio Baselga Carretero, Antoni Ribas, Theodore Scott Nowicki
Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade. Journal for immunotherapy of cancer 11 (5) (2023)
Luke Frankiw, Arun Singh, Cole Peters, Begoña Comin-Anduix, Beata Berent-Maoz, Mignonette Macabali, Kiana Shammaie, Crystal Quiros, Paula Kaplan-Lefko, Ignacio Baselga Carretero, Antoni Ribas, Theodore Scott Nowicki
Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade. Journal for immunotherapy of cancer 11 (5) (2023)
Theodore Scott Nowicki, Cole W Peters, Crystal Quiros, Conner K Kidd, Moe Kawakami, Alexandra M Klomhaus, Ignacio Baselga Carretero, Paula Kaplan-Lefko, Mignonette H Macabali, Ivan Perez Garcilazo, Beata Berent-Maoz, Begoña Comin-Anduix, Antoni Ribas
Infusion Product TNFα, Th2, and STAT3 Activities are Associated with Clinical Responses to Transgenic T-cell Receptor Cell Therapy. Cancer immunology research (2023)
Andrew W Hahn, Ashley V Menk, Dayana B Rivadeneira, Ryan C Augustin, Mingchu Xu, Jun Li, Xiaogang Wu, Aditya K Mishra, Tuba Nur Gide, Camelia Quek, Yan Zang, Christine N Spencer, Alexander M Menzies, Carrie R Daniel-MacDougall, Courtney W Hudgens, Theodore Scott Nowicki, Lauren E Haydu, Md Abdul Wadud Khan, Vancheswaran Gopalakrishnan, Elizabeth M Burton, Jared C Malke, Julie M Simon, Chantale Bernatchez, Nagireddy Putluri, Scott E Woodman, Vashisht Gopal Y N, Renato A Guerrieri, Grant M Fischer, Jian Wang, Khalida M Wani, John F Thompson, Jeffrey E Lee, Patrick Hwu, Nadim J Ajami, Jeffrey E Gershenwald, Georgina V Long, Richard A Scolyer, Michael T Tetzlaff, Alexander J F Lazar, Dirk Schadendorf, Jennifer A Wargo, Joanne M Jeter, Ralph J DeBerardinis, Han Liang, P Andrew Futreal, Jianhua Zhang, James S Wilmott, Weiyi Peng, Michael A Davies, Greg M Delgoffe, Yana G Najjar, Jennifer Leigh McQuade
Obesity is associated with altered tumor metabolism in metastatic melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Jack Pengfei Tang, Cole W Peters, Crystal Quiros, Xiaoyan Wang, Alexandra M Klomhaus, Reiko E Yamada, John M Timmerman, Theodore Bruce Moore, Theodore Scott Nowicki
Hypophosphatemia Due to Increased Effector Cell Metabolic Activity Is Associated with Neurotoxicity Symptoms in CD19-Targeted CAR T-cell Therapy. Cancer immunology research 10 (12) (2022)
Katie M Campbell, Maneesha Thaker, Egmidio Medina, Anusha Kalbasi, Arun Singh, Antoni Ribas, Theodore Scott Nowicki
Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy. Journal for immunotherapy of cancer 10 (3) (2022)